Howard University Telehealth Training Center
HUTTC Home | About | News | Current Projects | Past Projects | On-Demand Videos and Podcasts

5. Culturally Competent Care for Substance Users Diagnosed with HIV Disease

Common Comorbid Conditions

A variety of comorbid conditions commonly occur in HIV-positive substance users, particularly injection drug users.

Bacterial infections. Compared with HIV-negative injection drug users, HIV-positive injection drug users have a higher rate of certain bacterial infections, particularly skin and soft tissue infections, pneumonia, and endocarditis. [Selwyn 1988, Gordon 2005, Brett 2005, Wilson 2002] Patients who cannot or will not discontinue injecting drugs should be cautioned to clean the skin thoroughly before each injection, use sterile syringes each time, switch injection sites frequently, and avoid intramuscular injection. Healthcare providers should advise all patients in this population to maintain current vaccinations for tetanus, Streptococcus pneumoniae, and Haemophilus
influenza
B. Any suspicion of endocarditis should be investigated promptly.

Hepatitis. In the United States and Western Europe, approximately 25% of HIV-infected patients also have hepatitis C virus (HCV) infection, and among HIV-infected injection drug users, the rate of HCV infection is 72% to 95%. [Alter 2006] HIV/HCV coinfection is associated with faster progression of HCV-related liver disease and increased risk for nonadherence to HAART. [Braitstein 2006] The risks for nonadherence and potential for adverse drug reactions mean that practitioners must be exceptionally careful in designing treatment regimens for HCV/HIV coinfected patients. Chronic hepatitis B virus (HBV) infection is also common in HIV-infected vs HIV-negative substance users due to lower HBV clearance rates. In addition, Hepatitis A (HAV) and HBV vaccination are recommended for patients who do not show antibody evidence for immunity. [Mast 2006]

Sexually transmitted infections. Rates of sexually transmitted infections (STIs) among HIV-infected substance users are high, due to factors like risky behavior associated with drugs and alcohol and exchanging sex for drugs or money. Prevention counseling should be a part of patient management. Screening for common STIs should be readily available, female patients should have regular Pap smears due to the risk of neoplasia associated with human papilloma virus (HPV).

Tuberculosis. Due to concurrent problems such as homelessness, poverty, or a history of incarceration HIV-positive substance users are at greater risk for tuberculosis (TB) and should be routinely screened for the infection. DOT is recommended in this population, and the potential interactions among antiretroviral agents, TB therapies, and methadone require careful selection and monitoring of all medications.

Mental disorders. HIV-positive substance users have a high rate of mental disorders, and mental disorders are themselves a risk factor for HIV infection, partly because of high-risk behaviors. [Tegger 2008, Mijch 2006] All HIV-positive substance-using patients should be screened for mental disorders, as the triple diagnosis of HIV, drug use, and mental illness is common and increases the risk for delayed initiation of HAART. [Weaver 2008] Carefully integrated patient management is especially important for this group of patients.

« BACK

NEXT »